Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03403179 · ClinicalTrials.gov registry record · NA

Functional Remediation for Bipolar Disorder

A NA study of Bipolar Disorder, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT03403179 is a NA study of Bipolar Disorder that has completed, run by University of Michigan. The registered enrollment target is 30 participants, below the 333-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03403179, a NA study of Bipolar Disorder, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Bipolar Disorder is a major mood disorder with periodic mood episodes that may be very distressing, both to the individual and to others. When ill, the person is at particular risk for disruptions to social and occupational functioning, physical health, and even premature death. When not in an episode, individuals with BD may still be feeling well but have ongoing neurobiological processes, as well as the psychological sequelae from illness episodes, that can lead to subtle neurocognitive impairment that impedes overall functioning. This study is a test of an existing, published intervention that ameliorates deficits in functioning in euthymic bipolar individuals.

Conditions Studied

Interventions

  • OTHER Functional Remediation

Study Locations (1)

Michigan

  • University of Michigan Depression Center - Ann Arbor

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-11-17
Est. Completion 2018-12-20
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03403179

The ClinicalTrials.gov registry entry for NCT03403179 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 333-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (91% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 1 intervention - of which Functional Remediation is the first listed.

NCT03403179 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03403179 about?

NCT03403179 is a clinical study titled "Functional Remediation for Bipolar Disorder". Bipolar Disorder is a major mood disorder with periodic mood episodes that may be very distressing, both to the individual and to others. When ill, the person is at particular risk for disruptions to social and occupational functioning, physical health, and even premature death. When not in an episo...

What is the current status of trial NCT03403179?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-11-17. Estimated completion is 2018-12-20.

What conditions does trial NCT03403179 study?

This clinical trial studies the following conditions: Bipolar Disorder.

What interventions are being tested in trial NCT03403179?

The interventions under investigation include: Functional Remediation (OTHER).

Who is sponsoring clinical trial NCT03403179?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03403179 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.